The World Health Organization (WHO) provided updates on several important events hosted by the organization and its partners in June 2024 in Dhaka, Bangladesh: first Global Forum on Advancing Multisectoral and Multistakeholder Engagement and Accountability to End TB (23-24 June); #Youth2EndTB Townhall (23 June); annual meeting of the Stop TB Working Group on Public-Private Mix (PPM) for TB prevention and care (25-26 June); consultation on enhanced TB-PPM data dashboards with seven PPM priority countries (27 June). The WHO policy brief: "Public-Private Mix Data Dashboards for Enhanced Action and Accountability to End TB" was launched and disseminated at the consultation.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

Borstel researchers are the first to develop a biomarker to predict the occurrence of neuropathic adverse events during therapy for multidrug-resistant tuberculosis. The results have now been published in the journal Pathogens & Immunity.

Deadline for applications: 12 July 2024

RESIST-TB released its July 2024 newsletter with the latest updates and research publications on drug-resistant TB.

The SMART4TB Consortium hosted a webinar on 20 June 2024 about the consensus process and statement for earlier inclusion of pregnant women and persons in TB research. It featured advocates sharing their experiences with TB and pregnancy, and profiling SMART4TB studies that are responding to the call for inclusion.

The National Health Service (NHS) in England released Clinical commissioning policy statement, and accompanying documents, for the treatment for defined patients with rifampicin-resistant TB, multidrug-resistant TB, pre-extensively drug-resistant TB and extensively drug-resistant TB including bedaquiline and delamanid (all ages).

Using Kyle Rohde’s data and artificial intelligence, biotech company Atomwise narrowed its focus from millions of drugs to just 100, accelerating the search for new tuberculosis antibiotics.

A more accurate way to scan for tuberculosis (TB) has been developed by UK and US researchers, using positron emission tomography (PET).

Geneva, 27 June 2024 – The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) and Unitaid signed a new collaboration framework to advance equitable access to high-quality and affordable health products and innovations in low- and middle-income countries over the next three years.